Today's Trend
Encompass Health Corporation (NYSE: EHC) is getting mixed analyst attention after Zacks Research updated multiple earnings forecasts. The stock has been slightly lower as investors weigh a few downward revisions for near-term quarters against stronger outlooks for later years.
- Zacks Research raised its FY2027 EPS estimate for Encompass Health to $6.35 from $6.32, and also nudged FY2028 EPS higher to $7.16 from $7.13, signaling expectations for continued longer-term earnings growth.
- The firm also increased its Q1 2027 EPS estimate to $1.63 from $1.57 and Q1 2028 EPS to $1.80 from $1.73, which may support confidence in future operating performance.
- Zacks Research left several other estimates unchanged, including FY2026 EPS at $5.96 and the company’s broader earnings profile, while the consensus full-year estimate remains $5.97 per share.
- The analyst firm lowered near-term estimates for Q2 2026 to $1.46 from $1.49, Q3 2026 to $1.36 from $1.40, and Q4 2026 to $1.55 from $1.62, suggesting some caution around the next few quarters.
- Additional cuts were made to Q2 2027 EPS to $1.60 from $1.62 and Q4 2027 EPS to $1.64 from $1.65, reinforcing a mildly softer near-term earnings view.
Overall, the stock’s move appears tied to the balance between stronger long-term EPS expectations and slightly weaker short-term forecasts from Zacks Research.